新华制药:感谢您对公司关注与支持,感谢您的意见与建议

证星董秘互动
20 Feb

证券之星消息,新华制药(000756)02月20日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘,业内翰宇药业与华为团队合作探索AI制药,AI与制药的结合不仅能够加速药物研发进程,还能降低研发成本,提升药物质量,为医药行业带来诸多优势。请问董秘,如何看待AI制药领域未来的前景,以及公司未来在AI制药领域的战略布局?新华制药董秘:感谢您对公司关注与支持,感谢您的意见与建议。投资者:尊敬的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10